- Abirateron acetate2017 | First Faculty of Medicine
- Abiraterone acetate and quality of life of castration-resistant prostate cancer patients2013 | First Faculty of Medicine
- Enzalutamide and Abiraterone in the Treatment of Metastatic Castration-resistant Prostate Cancer after Chemotherapy2016 | First Faculty of Medicine
- Effectiveness and safety of abiraterone acetate treatment for metastatic castration-resistant prostate cancer post-chemotherapy2018 | First Faculty of Medicine
- Enzalutamide and abiraterone in the treatment of patients with metastatic castration-resistant prostate cancer treated previously with chemotherapy2023 | First Faculty of Medicine
- ARTA treatment of metastatic castration-resistant prostate cancer - case report2021 | First Faculty of Medicine
- What the results of current studies with enzalutamide say - a commentary on the studies2021 | Publication without faculty affiliation
- Report of University Hospital Hradec Králové to the clinical trial protocol No: 212082PCR3011Publication without faculty affiliation
- Abiraterone in patients with metastatic castration -resistant prostate cancer without prior chemotherapy : results of a study COU -AA- 3022014 | First Faculty of Medicine
- Research Report University Hospital for clinical assessment Go27983Publication without faculty affiliation
- Novel therapeutic options in prostate cancer before chemotherapy2013 | First Faculty of Medicine
- Metastatic prostate cancer - changes in treatment strategy2019 | First Faculty of Medicine
- Vhodný pacient pro léčbu abirateron acetátem2017 | First Faculty of Medicine
- Zkušenosti s léčbou abirateronem u pacienta s karcinomem prostaty2020 | First Faculty of Medicine
- Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate CancerPublication without faculty affiliation
- Preclinical evaluation of new formulation concepts for abiraterone acetate bioavailability enhancement based on the inhibition of pH-induced precipitation2020 | First Faculty of Medicine, Faculty of Science
- The importance of cooperation between urologist and oncologist in the treatment of castration-resistant prostate cancer2014 | First Faculty of Medicine
- The importance of cooperation between urologist and oncologist in the treatment of castration-resistant2014 | First Faculty of Medicine
- Efektivita a bezpečnost léčby abirateron acetátem u pacientů s metastatickým kastračně rezistentním karcinomem prostaty po chemoterapii - výsledky studie 212082PCR3001 v České republicePublication without faculty affiliation
- Expanded access protocol with abiraterone acetate for metastatic castration-resistant prostate cancer post-chemoterapy - results in Czech RepublicPublication without faculty affiliation
- Analysis of european patients enrolled in a global early access protocol with abiraterone acetate for metastatic castration-resistant prostate cancer progressing after chemotherapy2014 | First Faculty of Medicine
- New treatment options in hormone-sensitive prostate cancer +12019 | First Faculty of Medicine
- Current treatment options for metastatic castration-resistant prostate cancer2018 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Physical Education and Sport
- Pharmacokinetic Variability in Pre-Clinical Studies: Sample Study with Abiraterone in Rats and Implications for Short-Term Comparative Pharmacokinetic Study Designs2022 | First Faculty of Medicine, Faculty of Science
- Komentář ke studii: Cabazitaxel a abirateron acetát po selhání docetaxelu v léčbě pacientů s metastazujícím kastračně rezistentním karcinomem prostaty2015 | Third Faculty of Medicine
- Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer2017 | Faculty of Medicine in Hradec Králové
- Concomitant antihypertensive medication and outcome of patients with metastatic castration-resistant prostate cancer receiving enzalutamide or abiraterone acetate2024 | Faculty of Medicine in Pilsen
- Prostate cancer - cardiac complications of treatment2021 | First Faculty of Medicine
- Enzalutamide or Abiraterone Acetate With Prednisone in the Treatment of Metastatic Castration-resistant Prostate Cancer in Real-life Clinical Practice: A Long-term Single Institution Experience2023 | Faculty of Medicine in Pilsen
